The green tea catechin EGCG provides proof-of-concept for a pan-coronavirus attachment inhibitor
出版年份 2022 全文链接
标题
The green tea catechin EGCG provides proof-of-concept for a pan-coronavirus attachment inhibitor
作者
关键词
-
出版物
Scientific Reports
Volume 12, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-07-28
DOI
10.1038/s41598-022-17088-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Brilacidin, a COVID‐19 drug candidate, demonstrates broad‐spectrum antiviral activity against human coronaviruses OC43, 229E, and NL63 through targeting both the virus and the host cell
- (2022) Yanmei Hu et al. JOURNAL OF MEDICAL VIROLOGY
- The inhibitory effects of PGG and EGCG against the SARS-CoV-2 3C-like protease
- (2021) Wei-Chung Chiou et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- EGCG, a green tea polyphenol, inhibits human coronavirus replication in vitro
- (2021) Minsu Jang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Epigallocatechin-3-gallate, an active ingredient of Traditional Chinese Medicines, inhibits the 3CLpro activity of SARS-CoV-2
- (2021) Ashuai Du et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- The green tea catechin epigallocatechin gallate inhibits SARS-CoV-2 infection
- (2021) Lisa Henss et al. JOURNAL OF GENERAL VIROLOGY
- Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2
- (2021) Tia A. Tummino et al. SCIENCE
- Epigallocatechin gallate from green tea effectively blocks infection of SARS-CoV-2 and new variants by inhibiting spike binding to ACE2 receptor
- (2021) Jinbiao Liu et al. Cell and Bioscience
- Heparan Sulfate Proteoglycans as Attachment Factor for SARS-CoV-2
- (2021) Lin Liu et al. ACS Central Science
- Epigallocatechin Gallate (EGCG), a Green Tea Polyphenol, Reduces Coronavirus Replication in a Mouse Model
- (2021) Rackhyun Park et al. Viruses-Basel
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays
- (2020) Katharine H. D. Crawford et al. Viruses-Basel
- Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2
- (2020) James Brett Case et al. Cell Host & Microbe
- SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2
- (2020) Thomas Mandel Clausen et al. CELL
- Tea Polyphenols EGCG and Theaflavin Inhibit the Activity of SARS-CoV-2 3CL-Protease In Vitro
- (2020) Minsu Jang et al. Evidence-based Complementary and Alternative Medicine
- Genetic Screens Identify Host Factors for SARS-CoV-2 and Common Cold Coronaviruses
- (2020) Ruofan Wang et al. CELL
- Canine Respiratory Coronavirus, Bovine Coronavirus, and Human Coronavirus OC43: Receptors and Attachment Factors
- (2019) Artur Szczepanski et al. Viruses-Basel
- What are the drugs of the future?
- (2018) Huy X. Ngo et al. MedChemComm
- A Review of the Antiviral Role of Green Tea Catechins
- (2017) et al. MOLECULES
- Epigallocatechin gallate inhibits hepatitis B virus via farnesoid X receptor alpha
- (2016) Jun Xu et al. Journal of Natural Medicines
- SARS-like WIV1-CoV poised for human emergence
- (2016) Vineet D. Menachery et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Human Coronavirus HKU1 Spike Protein UsesO-Acetylated Sialic Acid as an Attachment Receptor Determinant and Employs Hemagglutinin-Esterase Protein as a Receptor-Destroying Enzyme
- (2015) Xingchuan Huang et al. JOURNAL OF VIROLOGY
- Epigallocatechin-3-gallate opposes HBV-induced incomplete autophagy by enhancing lysosomal acidification, which is unfavorable for HBV replication
- (2015) L Zhong et al. Cell Death & Disease
- (−)-Epigallocatechin-3-gallate inhibits entry of hepatitis B virus into hepatocytes
- (2014) Hsiu-Chen Huang et al. ANTIVIRAL RESEARCH
- Human Coronavirus NL63 Utilizes Heparan Sulfate Proteoglycans for Attachment to Target Cells
- (2014) A. Milewska et al. JOURNAL OF VIROLOGY
- A Small Molecule Inhibits Virion Attachment to Heparan Sulfate- or Sialic Acid-Containing Glycans
- (2014) Che C. Colpitts et al. JOURNAL OF VIROLOGY
- Clinical Impact of Human Coronaviruses 229E and OC43 Infection in Diverse Adult Populations
- (2013) E. E. Walsh et al. JOURNAL OF INFECTIOUS DISEASES
- Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor
- (2013) Xing-Yi Ge et al. NATURE
- Green tea polyphenols in drug discovery: a success or failure?
- (2011) Thomas J Smith Expert Opinion on Drug Discovery
- The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry
- (2011) Sandra Ciesek et al. HEPATOLOGY
- (−)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry
- (2011) Noémie Calland et al. HEPATOLOGY
- Epigallocatechin gallate inhibits HBV DNA synthesis in a viral replication - inducible cell line
- (2011) Wei He WORLD JOURNAL OF GASTROENTEROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More